View this API's:

Patents at Patent & Trademark Office Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S10 9/5/02 9/11/02 9/5/02 7/8/03 Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S-005, S-009 10/7/02 10/11/01 Arimidex (anastrozole) Tablets, AstraZeneca NDA 20-541/S-006 9/1/00 9/21/00 7/12/01 7/12/01 Arimidex Indication: for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer. ARIMIDEX 7 (anastrozole) Tablets, AstraZeneca, Labeling Revision   For the latest approval information, locate this drug using this index.